Intelligence · Clinical Development
Pipeline search results
Programs matching “Bristol Myers Squibb” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 40 pipeline programs matching "Bristol Myers Squibb" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
AI455-110
Bristol-Myers Squibb
HIV Infections
1 trial -
ATV
Bristol-Myers Squibb
HIV Infections
1 trial -
Daclatasvir
Bristol-Myers Squibb
Hepatitis C Virus Infection
2 trials -
Deucravacitinib
Bristol-Myers Squibb
Sjögren's Syndrome
1 trial -
Enoxaparin
Bristol-Myers Squibb
Deep Vein Thrombosis
1 trial -
Entecavir
Bristol-Myers Squibb
Hepatitis B, Chronic
1 trial -
Ipilimumab
Bristol-Myers Squibb
Melanoma
1 trial -
KarXT
Bristol-Myers Squibb
Bipolar Disorder Type I With Mania
1 trial -
KarXT
Bristol-Myers Squibb
Irritability Associated With Autism Spectrum Disorder
1 trial -
Muraglitazar
Bristol-Myers Squibb
Diabetes, Type 2
1 trial -
NKTR-214
Bristol-Myers Squibb
Melanoma
1 trial -
Nivolumab
Bristol-Myers Squibb
Bladder Cancer
1 trial -
Nivolumab
Bristol-Myers Squibb
Gastric Cancer
1 trial -
Nivolumab
Bristol-Myers Squibb
Head and Neck Cancer
1 trial -
Nivolumab
Bristol-Myers Squibb
Brain Neoplasms
1 trial -
Nivolumab
Bristol-Myers Squibb
Colorectal Cancer
1 trial -
Repotrectinib
Bristol-Myers Squibb
Carcinoma, Non-Small-Cell Lung
1 trial -
Vinflunine
Bristol-Myers Squibb
Stomach Cancer
1 trial -
muraglitazar
Bristol-Myers Squibb
Diabetes Mellitus, Type 2
1 trial -
nivolumab
Bristol-Myers Squibb
Breast Cancer
1 trial -
warfarin
Bristol-Myers Squibb
Atrial Fibrillation
1 trial -
BMS-986165
Bristol-Myers Squibb
Lupus Nephritis
1 trial -
BMS-986165
Bristol-Myers Squibb
Systemic Lupus Erythematosus
1 trial -
BMS-986165
Bristol-Myers Squibb
Granulomatous Colitis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.